Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy

23 Aug 2022

Abstract excerpt

T-cell immunoglobulin mucin 3 (TIM-3) has emerged as a promising immune checkpoint target in cancer therapy. However, the profile of the hepatitis A virus cellular receptor 2 (HAVCR2) gene, encoding TIM-3 expression, is still obscure, along with its role in cancer immunity and prognosis. This study comprehensively analyzed HAVCR2 expression patterns in pan-cancer and underlined its potential value for immune...

Topics

Join the communities discussing this publication.

Cancer Mechanisms and Therapy
Galectins and Cancer Biology
Peptidase Inhibition and Analysis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36081997
DOI: 10.3389/fgene.2022.972664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapyPMID 36081997Read ↗

Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressantsSemantic proximity Read ↗

CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and ExosomesSemantic proximity Read ↗

Comprehensive analysis of long non-coding RNA MAGI2-AS3 as a key immune regulator, therapeutic target and prognostic biomarker across pan-cancer with a focus on colorectal cancerSemantic proximity Read ↗

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapySemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHCSemantic proximity Read ↗

Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis.Semantic proximity Read ↗

Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics AnalysisSemantic proximity Read ↗

Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC.Semantic proximity Read ↗

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.Semantic proximity Read ↗

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological RoleSemantic proximity Read ↗

Pan-cancer and single-cell analyses reveal LAMP3 as a biomarker associated with cancer prognosis and immune infiltrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.